{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:03:35Z","timestamp":1746335015612,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T00:00:00Z","timestamp":1460937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Finnish Cancer Society"},{"DOI":"10.13039\/501100005634","name":"Suomen Hammasl\u00e4\u00e4k\u00e4riseura Apollonia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005634","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Maritza and Reino Salonen Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00405-016-3964-y","type":"journal-article","created":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T04:24:22Z","timestamp":1460953462000},"page":"3905-3911","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Does securin expression have significance in prognostication of oral tongue cancer? A pilot study"],"prefix":"10.1007","volume":"273","author":[{"given":"Ilkka","family":"Heikkinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alhadi","family":"Almangush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaana","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim O.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joonas H.","family":"Kauppila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura K.","family":"M\u00e4kinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caj","family":"Haglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pentti","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuula","family":"Salo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilmo","family":"Leivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,18]]},"reference":[{"issue":"7","key":"3964_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.ijom.2014.01.014","volume":"43","author":"PC Rodrigues","year":"2014","unstructured":"Rodrigues PC, Miguel MC, Bagordakis E, Fonseca FP, de Aquino SN, Santos-Silva AR, Lopes MA, Graner E, Salo T, Kowalski LP, Coletta RD (2014) Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg 43(7):795\u2013801. doi: 10.1016\/j.ijom.2014.01.014","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"5","key":"3964_CR2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/sj.bjc.6605544","volume":"102","author":"V Hayry","year":"2010","unstructured":"Hayry V, Makinen LK, Atula T, Sariola H, Makitie A, Leivo I, Keski-Santti H, Lundin J, Haglund C, Hagstrom J (2010) Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer 102(5):892\u2013897. doi: 10.1038\/sj.bjc.6605544","journal-title":"Br J Cancer"},{"issue":"3\u20134","key":"3964_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-007-9082-y","volume":"26","author":"D Sano","year":"2007","unstructured":"Sano D, Myers JN (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26(3\u20134):645\u2013662. doi: 10.1007\/s10555-007-9082-y","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"3964_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.oraloncology.2010.06.006","volume":"46","author":"IO Bello","year":"2010","unstructured":"Bello IO, Soini Y, Salo T (2010) Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol 46(9):630\u2013635. doi: 10.1016\/j.oraloncology.2010.06.006","journal-title":"Oral Oncol"},{"issue":"3","key":"3964_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/his.12184","volume":"63","author":"TM Soland","year":"2013","unstructured":"Soland TM, Brusevold IJ (2013) Prognostic molecular markers in cancer\u2014quo vadis? Histopathology 63(3):297\u2013308. doi: 10.1111\/his.12184","journal-title":"Histopathology"},{"issue":"3","key":"3964_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/jop.12115","volume":"43","author":"IM Moura","year":"2014","unstructured":"Moura IM, Delgado ML, Silva PM, Lopes CA, do Amaral JB, Monteiro LS, Bousbaa H (2014) High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med 43(3):225\u2013231. doi: 10.1111\/jop.12115","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"3964_CR7","doi-asserted-by":"publisher","first-page":"e98160","DOI":"10.1371\/journal.pone.0098160","volume":"9","author":"HS Kim","year":"2014","unstructured":"Kim HS, Koh JS, Choi YB, Ro J, Kim HK, Kim MK, Nam BH, Kim KT, Chandra V, Seol HS, Noh WC, Kim EK, Park J, Bae CD, Hong KM (2014) Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancer. PLoS One 9(6):e98160. doi: 10.1371\/journal.pone.0098160","journal-title":"PLoS One"},{"issue":"4","key":"3964_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2559.2011.04107.x","volume":"60","author":"H Karra","year":"2012","unstructured":"Karra H, Pitkanen R, Nykanen M, Talvinen K, Kuopio T, Soderstrom M, Kronqvist P (2012) Securin predicts aneuploidy and survival in breast cancer. Histopathology 60(4):586\u2013596. doi: 10.1111\/j.1365-2559.2011.04107.x","journal-title":"Histopathology"},{"issue":"6","key":"3964_CR9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.surg.2013.06.058","volume":"154","author":"MJ Demeure","year":"2013","unstructured":"Demeure MJ, Coan KE, Grant CS, Komorowski RA, Stephan E, Sinari S, Mount D, Bussey KJ (2013) PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target. Surgery 154(6):1405\u20131416. doi: 10.1016\/j.surg.2013.06.058 (discussion 1416)","journal-title":"Surgery"},{"issue":"1","key":"3964_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/sj.cdd.4402254","volume":"15","author":"JA Bernal","year":"2008","unstructured":"Bernal JA, Roche M, Mendez-Vidal C, Espina A, Tortolero M, Pintor-Toro JA (2008) Proliferative potential after DNA damage and non-homologous end joining are affected by loss of securin. Cell Death Differ 15(1):202\u2013212. doi: 10.1038\/sj.cdd.4402254","journal-title":"Cell Death Differ"},{"issue":"47","key":"3964_CR11","doi-asserted-by":"publisher","first-page":"36502","DOI":"10.1074\/jbc.C000546200","volume":"275","author":"R Yu","year":"2000","unstructured":"Yu R, Heaney AP, Lu W, Chen J, Melmed S (2000) Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis. J Biol Chem 275(47):36502\u201336505. doi: 10.1074\/jbc.C000546200","journal-title":"J Biol Chem"},{"issue":"6","key":"3964_CR12","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.21181","volume":"43","author":"T Fujii","year":"2006","unstructured":"Fujii T, Nomoto S, Koshikawa K, Yatabe Y, Teshigawara O, Mori T, Inoue S, Takeda S, Nakao A (2006) Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology 43(6):1267\u20131275. doi: 10.1002\/hep.21181","journal-title":"Hepatology"},{"issue":"5","key":"3964_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/hed.21531","volume":"33","author":"LJ Liao","year":"2011","unstructured":"Liao LJ, Hsu YH, Yu CH, Chiang CP, Jhan JR, Chang LC, Lin JJ, Lou PJ (2011) Association of pituitary tumor transforming gene expression with early oral tumorigenesis and malignant progression of precancerous lesions. Head Neck 33(5):719\u2013726. doi: 10.1002\/hed.21531","journal-title":"Head Neck"},{"issue":"9","key":"3964_CR14","doi-asserted-by":"publisher","first-page":"8801","DOI":"10.1007\/s13277-014-2143-2","volume":"35","author":"E Zhang","year":"2014","unstructured":"Zhang E, Liu S, Xu Z, Huang S, Tan X, Sun C, Lu L (2014) Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial\u2013mesenchymal transition (EMT) in SCC15 cells. Tumour Biol 35(9):8801\u20138811. doi: 10.1007\/s13277-014-2143-2","journal-title":"Tumour Biol"},{"issue":"5","key":"3964_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1600-0714.2011.01110.x","volume":"41","author":"LK Makinen","year":"2012","unstructured":"Makinen LK, Hayry V, Atula T, Haglund C, Keski-Santti H, Leivo I, Makitie A, Passador-Santos F, Bockelman C, Salo T, Sorsa T, Hagstrom J (2012) Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer. J Oral Pathol Med 41(5):394\u2013399. doi: 10.1111\/j.1600-0714.2011.01110.x","journal-title":"J Oral Pathol Med"},{"issue":"12","key":"3964_CR16","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1038\/bjc.2014.252","volume":"110","author":"H Karra","year":"2014","unstructured":"Karra H, Repo H, Ahonen I, Loyttyniemi E, Pitkanen R, Lintunen M, Kuopio T, Soderstrom M, Kronqvist P (2014) Cdc20 and securin overexpression predict short-term breast cancer survival. Br J Cancer 110(12):2905\u20132913. doi: 10.1038\/bjc.2014.252","journal-title":"Br J Cancer"},{"issue":"7","key":"3964_CR17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jjco\/hyf058","volume":"32","author":"Y Shibata","year":"2002","unstructured":"Shibata Y, Haruki N, Kuwabara Y, Nishiwaki T, Kato J, Shinoda N, Sato A, Kimura M, Koyama H, Toyama T, Ishiguro H, Kudo J, Terashita Y, Konishi S, Fujii Y (2002) Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol 32(7):233\u2013237","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"3964_CR18","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3109\/0284186X.2011.584327","volume":"50","author":"ST Avoranta","year":"2011","unstructured":"Avoranta ST, Korkeila EA, Minn HR, Syrjanen KJ, Pyrhonen SO, Sundstrom JT (2011) Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo)radiotherapy. Acta Oncol 50(8):1158\u20131166. doi: 10.3109\/0284186X.2011.584327","journal-title":"Acta Oncol"},{"issue":"5426","key":"3964_CR19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1126\/science.285.5426.418","volume":"285","author":"H Zou","year":"1999","unstructured":"Zou H, McGarry TJ, Bernal T, Kirschner MW (1999) Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285(5426):418\u2013422","journal-title":"Science"},{"issue":"7","key":"3964_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/modpathol.3800382","volume":"18","author":"S Ogbagabriel","year":"2005","unstructured":"Ogbagabriel S, Fernando M, Waldman FM, Bose S, Heaney AP (2005) Securin is overexpressed in breast cancer. Mod Pathol 18(7):985\u2013990. doi: 10.1038\/modpathol.3800382","journal-title":"Mod Pathol"},{"issue":"9205","key":"3964_CR21","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0140-6736(99)10238-1","volume":"355","author":"AP Heaney","year":"2000","unstructured":"Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S (2000) Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355(9205):716\u2013719. doi: 10.1016\/S0140-6736(99)10238-1","journal-title":"Lancet"},{"issue":"2","key":"3964_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/sj.bjc.6604475","volume":"99","author":"K Talvinen","year":"2008","unstructured":"Talvinen K, Tuikkala J, Nevalainen O, Rantanen A, Hirsimaki P, Sundstrom J, Kronqvist P (2008) Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer. Br J Cancer 99(2):335\u2013340. doi: 10.1038\/sj.bjc.6604475","journal-title":"Br J Cancer"},{"issue":"10","key":"3964_CR23","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1158\/1535-7163.MCT-13-0405","volume":"13","author":"C Castilla","year":"2014","unstructured":"Castilla C, Flores ML, Medina R, Perez-Valderrama B, Romero F, Tortolero M, Japon MA, Saez C (2014) Prostate cancer cell response to paclitaxel is affected by abnormally expressed securin PTTG1. Mol Cancer Ther 13(10):2372\u20132383. doi: 10.1158\/1535-7163.MCT-13-0405","journal-title":"Mol Cancer Ther"},{"key":"3964_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cbi.2014.06.006","volume":"220","author":"YT Huang","year":"2014","unstructured":"Huang YT, Lin CI, Chien PH, Tang TT, Lin J, Chao JI (2014) The depletion of securin enhances butein-induced apoptosis and tumor inhibition in human colorectal cancer. Chem Biol Interact 220:41\u201350. doi: 10.1016\/j.cbi.2014.06.006","journal-title":"Chem Biol Interact"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-016-3964-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-016-3964-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-016-3964-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-016-3964-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T14:16:15Z","timestamp":1559052975000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-016-3964-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,18]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["3964"],"URL":"https:\/\/doi.org\/10.1007\/s00405-016-3964-y","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"type":"print","value":"0937-4477"},{"type":"electronic","value":"1434-4726"}],"subject":[],"published":{"date-parts":[[2016,4,18]]}}}